Effects of high-amount–high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis

 

 Buy Article Permissions and Reprints

Summary

Physical activity is associated with cardiovascular risk reduction, but the effects of exercise on platelet activation remain controversial. We investigated the effects of regular high-amount, high intensity aerobic exercise on in vivo thromboxane (TX)-dependent platelet activation and plasma levels of platelet-derived proteins, CD40L and P-selectin, and whether platelet variables changes may be related to changes in high-density lipoprotein (HDL) and in the extent of oxidative stress and oxidative stress-related inflammation, as reflected by urinary isoprostane excretion and endogenous soluble receptor for advanced glycation end-products (esRAGE), respectively. Urinary excretion of 11-dehydro-TXB₂ and 8-iso-prostaglandin (PG)F_2α and plasma levels of P-selectin, CD40L and esRAGE were measured before and after a eight-week standardised aerobic high-amount–high-intensity training program in 22 sedentary subjects with low-to-intermediate risk. Exercise training had a clear beneficial effect on HDL cholesterol (+10%, p=0.027) and triglyceride (-27%, p=0.008) concentration. In addition, a significant (p<0.0001) decrease in urinary 11-dehydro-TXB₂ (26%), 8-iso-PGF_2α (21 %), plasma P-selectin (27%), CD40L (35%) and a 61% increase in esRAGE were observed. Multiple regression analysis revealed that urinary 8-iso-PGF_2α [beta=0.33, SEM=0.116, p=0.027] and esRAGE (beta=-0.30, SEM=31.3, p=0.046) were the only significant predictors of urinary 11-dehydro-TXB₂ excretion rate over the training period. In conclusion, regular high-amount–high-intensity exercise training has broad beneficial effects on platelet activation markers, paralleled and possibly associated with changes in the lipoprotein profile and in markers of lipid peroxidation and AGE/RAGE axis. Our findings may help explaining why a similar amount of exercise exerts significant benefits in preventing cardiovascular events.

• References

• 1 Thompson PD, Franklin BA, Balady GJ. et al. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 2007; 115: 2358-2368.
  CrossrefPubMedGoogle Scholar
• 2 Blair SN, Kohl 3rd HW, Barlow CE. et al. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. J Am Med Assoc 1995; 273: 1093-1098.
  CrossrefPubMedGoogle Scholar
• 3 Kokkinos P, Myers J, Faselis C. et al. Exercise capacity and mortality in older men: a 20-year follow-up study. Circulation 2010; 122: 790-797.
  CrossrefPubMedGoogle Scholar
• 4 Leon AS, Connett J, Jacobs Jr DR. et al. Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial. J Am Med Assoc 1987; 258: 2388-2395.
  CrossrefPubMedGoogle Scholar
• 5 Paffenbarger Jr RS, Hyde RT, Wing AL. et al. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986; 314: 605-613.
  CrossrefPubMedGoogle Scholar
• 6 Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 2001; 33 (Suppl. 06) S502-515 discussion S528-529.
  CrossrefPubMedGoogle Scholar
• 7 Zoppini G, Targher G, Zamboni C. et al. Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 2006; 16: 543-549.
  CrossrefPubMedGoogle Scholar
• 8 Kodama S, Tanaka S, Saito K. et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med 2007; 167: 999-1008.
  CrossrefPubMedGoogle Scholar
• 9 Kraus WE, Houmard JA, Duscha BD. et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002; 347: 1483-1492.
  CrossrefPubMedGoogle Scholar
• 10 Kraus WE, Torgan CE, Duscha BD. et al. Studies of a targeted risk reduction intervention through defined exercise (STRRIDE). Med Sci Sports Exerc 2001; 33: 1774-1784.
  CrossrefPubMedGoogle Scholar
• 11 Slentz CA, Houmard JA, Johnson JL. et al. Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol 2007; 103: 432-442.
  CrossrefPubMedGoogle Scholar
• 12 Kestin AS, Ellis PA, Barnard MR. et al. Effect of strenuous exercise on platelet activation state and reactivity. Circulation 1993; 88: 1502-1511.
  CrossrefPubMedGoogle Scholar
• 13 Li N, Wallén NH, Hjemdahl P. Evidence for prothrombotic effects of exercise and limited protection by aspirin. Circulation 1999; 100: 1374-1379.
  CrossrefPubMedGoogle Scholar
• 14 Wang JS, Li YS, Chen JC. et al. Effects of exercise training and deconditioning on platelet aggregation induced by alternating shear stress in men. Arterioscler Thromb Vasc Biol 2005; 25: 454-460.
  CrossrefPubMedGoogle Scholar
• 15 Thrall G, Lip GY. Exercise and the prothrombotic state: a paradox of cardiovascular prevention or an enhanced prothrombotic state?. Arterioscler Thromb Vasc Biol 2005; 25: 265-266.
  CrossrefPubMedGoogle Scholar
• 16 Ferroni P, Riandino S, Vazzana N. et al. Biomarkers of platelet activation in acute coronary syndromes. Thromb Haemost 2012; 108: 1109-1123.
  Article in Thieme ConnectPubMedGoogle Scholar
• 17 Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357: 2482-2494.
  CrossrefPubMedGoogle Scholar
• 18 Davì G, Guagnano MT, Ciabattoni G. et al. Platelet activation in obese women: role of inflammation and oxidant stress. J Am Med Assoc 2002; 288: 2008-2014.
  CrossrefPubMedGoogle Scholar
• 19 Patrono C, Falco A, Davì G. Isoprostane formation and inhibition in athero-thrombosis. Curr Opin Pharmacol 2005; 5: 198-203.
  CrossrefPubMedGoogle Scholar
• 20 Basili S, Pacini G, Guagnano MT. et al. Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol 2006; 48: 2531-2538.
  CrossrefPubMedGoogle Scholar
• 21 Santilli F, Vazzana N, Liani R. et al. Platelet activation in obesity and metabolic syndrome. Obes Rev 2012; 13: 27-42.
  CrossrefPubMedGoogle Scholar
• 22 Santilli F, Basili S, Ferroni P. et al. CD40/CD40L system and vascular disease. Intern Emerg Med 2007; 2: 256-268.
  CrossrefPubMedGoogle Scholar
• 23 Santilli F, Vazzana N, Bucciarelli LG. et al. Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr Med Chem 2009; 16: 940-952.
  CrossrefPubMedGoogle Scholar
• 24 D'Agostino Sr RB, Vasan RS, Pencina MJ. et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-753.
  CrossrefPubMedGoogle Scholar
• 25 Wang Z, Ciabattoni G, Créminon C. et al. Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther 1995; 275: 94-100.
  PubMedGoogle Scholar
• 26 Ciabattoni G, Pugliese F, Davi G. et al. Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man. Biochim Biophys Acta 1989; 992: 66-70.
  CrossrefPubMedGoogle Scholar
• 27 Davì G, Averna M, Catalano I. et al. Increased thromboxane biosynthesis in type IIa hypercholesterolemia. Circulation 1992; 85: 1792-1798.
  CrossrefPubMedGoogle Scholar
• 28 Santilli F, Formoso G, Sbraccia P. et al. Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. J Thromb Haemost 2010; 8: 828-837.
  CrossrefPubMedGoogle Scholar
• 29 Varo N, Nuzzo R, Natal C. et al. Influence of pre-analytical and analytical factors on soluble CD40L measurements. Clin Sci (Lond) 2006; 111: 341-347.
  CrossrefPubMedGoogle Scholar
• 30 Davì G, Romano M, Mezzetti A. et al. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 1998; 17 (97) 953-957.
  CrossrefPubMedGoogle Scholar
• 31 Santilli F, Rocca B, De Cristofaro R. et al. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". J Am Coll Cardiol 2009; 53: 667-677.
  CrossrefPubMedGoogle Scholar
• 32 Barlow CE, Defina LF, Radford NB. et al. Cardiorespiratory fitness and long-term survival in “low-risk” adults. J Am Heart Assoc 2012; 1: e001354.
  CrossrefPubMedGoogle Scholar
• 33 El-Sayed MS, Ali N, El-Sayed Ali Z. Aggregation and activation of blood platelets in exercise and training. Sports Med 2005; 35: 11-22.
  CrossrefPubMedGoogle Scholar
• 34 Gibbs CR, Blann AD, Edmunds E. et al. Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm. Clin Cardiol 2001; 24: 724-729.
  CrossrefPubMedGoogle Scholar
• 35 Li-Saw-Hee FL, Blann AD, Edmunds E. et al. Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation. Clin Cardiol 2001; 24: 409-414.
  CrossrefPubMedGoogle Scholar
• 36 Ahmadizad S, El-Sayed MS, Maclaren DP. Responses of platelet activation and function to a single bout of resistence exercise and racovery. Clin Hemorheol Microcirc 2006; 25: 159-168.
  PubMedGoogle Scholar
• 37 Rauramo I, Ilmonen S, Viinikka L. et al. Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise. Obstet Gynecol 1995; 85: 1027-1030.
  CrossrefPubMedGoogle Scholar
• 38 Wennmalm A, Nowalk J, Bjuro T. Excretion of thromboxane A2 and prostacyclin metabolites before and after exercise testing in patients with and without signs of ischemic heart disease. Circulation 1990; 82: 1737-1743.
  CrossrefPubMedGoogle Scholar
• 39 Gangemi S, Luciotti G, D'Urbano E. et al. Physical exercise increases urinary excretion of lipoxin A4 and related compounds. J Appl Physiol 2003; 94: 2237-2240.
  CrossrefPubMedGoogle Scholar
• 40 Li N, Wallen NH, Hjemdahl P. Evidence for prothrombotic effects of exercise and limited protection by aspirin. Circulation 1999; 100: 1374-1379.
  CrossrefPubMedGoogle Scholar
• 41 Stewart JK. Exercise training and the cardiovascular consequences of type diabetes and hypertension: plausible mechanisms for improving cardiovascular health. J Am Med Assoc 2002; 288: 1622-1631.
  CrossrefPubMedGoogle Scholar
• 42 Yoshikawa D, Ishii H, Kurebayashi N. et al. Association of cardiorespiratory fitness with characteristics of coronary plaque: Assessment using integrated back-scatter intravascular ultrasound and optical coherence tomography. Int J Cardiol 2013; 162: 123-128.
  CrossrefPubMedGoogle Scholar
• 43 Rauramaa R, Salonen JT, Seppanen K. et al. Inhibition of platelect aggregability by moderate-intensity physical exercise: a randomized clinical trial in overweight men. Circulation 1986; 74: 939-944.
  CrossrefPubMedGoogle Scholar
• 44 FitzGerald GA, Pedersen AK, Patrono C. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation 1983; 67: 1174-1177.
  CrossrefPubMedGoogle Scholar
• 45 Patrono C, Ciabattoni G, Pugliese F. et al. Estimated rate of thromboxane secretion into the circulation of normal humans. J Clin Invest 1986; 77: 590-594.
  CrossrefPubMedGoogle Scholar
• 46 Ferroni P, Santilli F, Guadagni F. et al. Contribution of platelet-derived CD40L ligand to inflammation, thrombosis and neoangiogenesis. Curr Med Chem 2007; 14: 2170-2180.
  CrossrefPubMedGoogle Scholar
• 47 Bjornstad HH, Bruvik J, Bjornstad AB. et al. Exercise training decreases plasma levels of soluble CD40 ligand and P-selectin in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2008; 15: 43-48.
  CrossrefPubMedGoogle Scholar
• 48 Campbell PT, Gross MD, Potter JD. et al. Effect of exercise on oxidative stress: a 12-month randomized, controlled trial. Med Sci Sports Exerc 2010; 42: 1448-1453.
  CrossrefPubMedGoogle Scholar
• 49 Choi KM, Han KA, Ahn HJ. et al. Effects of exercise on sRAGE levels and cardiometabolic risk factors in patients with type 2 diabetes: a randomized controlled trial. J Clin Endocrinol Metab 2012; 97: 3751-3758.
  CrossrefPubMedGoogle Scholar
• 50 Vazzana N, Santilli F, Cuccurullo C. et al. Soluble forms or RAGE in internal medicine. Intern Emerg Med 2009; 4: 389-401.
  CrossrefPubMedGoogle Scholar
• 51 Voight BF, Peloso GM, Orho-Melander M. et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012; 380: 572-580.
  CrossrefPubMedGoogle Scholar
• 52 Toth PP, Davidson MH. High-density lipoproteins: marker of cardiovascular risk and therapeutic target. J Clin Lipidol 2010; 4: 359-364.
  CrossrefPubMedGoogle Scholar
• 53 Nofer JR, Walter M, Kehrel B. et al. HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinosite-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris phosphate. Arterioscler Thromb Vasc Biol 1998; 18: 861-869.
  CrossrefPubMedGoogle Scholar
• 54 Vazzana N, Guagnano MT, Cuccurullo C. et al. Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress. J Clin Endocrinol Metab 2012; 97: E1726-1730.
  CrossrefPubMedGoogle Scholar
• 55 Sebeková K, Krivošíková Z, Gajdoš M. Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects. Clin Chem Lab Med 2013; 18: 1-11.
  PubMedGoogle Scholar
• 56 Kotani K, Caccavello R, Sakane N. et al. Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly Subjects. J Clin Med Res 2011; 3: 252-257.
  PubMedGoogle Scholar
• 57 Lakka TA, Lakka HM, Rankinen T. et al. Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study. Eur Heart J 2005; 26: 2018-2025.
  CrossrefPubMedGoogle Scholar
• 58 Okita K, Nishijima H, Murakami T. et al. Can exercise training with weight loss lower serum C-reactive protein levels?. Arterioscler Thromb Vasc Biol 2004; 24: 1868-1873.
  CrossrefPubMedGoogle Scholar
• 59 Vanhees L, Geladas N, Hansen D. et al. Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR. Part II. Eur J Prev Cardiol 2012; 19: 1005-1033.
  CrossrefPubMedGoogle Scholar
• 60 Boden WE, Franklin BA, Wenger NK. Physical Activity and Structured Exercise for Patients With Stable Ischemic Heart Disease. J Am Med Assoc 2013; 309: 143-144.
  CrossrefPubMedGoogle Scholar

• Supplementary Material